de Bruijn EA - Search Results

1

Early destruction of tumor vasculature in tumor necrosis factor-alpha-based isolated limb perfusion is responsible for tumor response.

Hoving S, Seynhaeve AL, van Tiel ST, aan de Wiel-Ambagtsheer G, de Bruijn EA, Eggermont AM, ten Hagen TL. Hoving S, et al. Among authors: de bruijn ea. Anticancer Drugs. 2006 Sep;17(8):949-59. doi: 10.1097/01.cad.0000224450.54447.b3. Anticancer Drugs. 2006. PMID: 16940805

2

Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.

Brunstein F, Hoving S, Seynhaeve AL, van Tiel ST, Guetens G, de Bruijn EA, Eggermont AM, ten Hagen TL. Brunstein F, et al. Among authors: de bruijn ea. J Natl Cancer Inst. 2004 Nov 3;96(21):1603-10. doi: 10.1093/jnci/djh300. J Natl Cancer Inst. 2004. PMID: 15523089

3

Synergistic antitumor response of interleukin 2 with melphalan in isolated limb perfusion in soft tissue sarcoma-bearing rats.

Hoving S, Brunstein F, aan de Wiel-Ambagtsheer G, van Tiel ST, de Boeck G, de Bruijn EA, Eggermont AM, ten Hagen TL. Hoving S, et al. Among authors: de bruijn ea, de boeck g. Cancer Res. 2005 May 15;65(10):4300-8. doi: 10.1158/0008-5472.CAN-04-2214. Cancer Res. 2005. PMID: 15899822 Free article.

4

Decreased response rates by the combination of histamine and IL-2 in melphalan-based isolated limb perfusion.

Brunstein F, Hoving S, aan de Wiel-Ambagtsheer G, de Bruijn EA, Guetens G, Eggermont AM, ten Hagen TL. Brunstein F, et al. Among authors: de bruijn ea. Cancer Immunol Immunother. 2007 Apr;56(4):573-80. doi: 10.1007/s00262-006-0206-y. Epub 2006 Aug 1. Cancer Immunol Immunother. 2007. PMID: 16896966 Free PMC article.

5

The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model.

Ten Hagen TL, Seynhaeve AL, de Wiel-Ambagtsheer Ga, de Bruijn EA, van Tiel ST, Ruegg C, Meyring M, Grell M, Goodman SL, Eggermont AM. Ten Hagen TL, et al. Among authors: de bruijn ea. Int J Cancer. 2013 Jun 1;132(11):2694-704. doi: 10.1002/ijc.27940. Epub 2012 Dec 5. Int J Cancer. 2013. PMID: 23152080

6

Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan, and mitomycin C using balloon catheter techniques: a pharmacokinetic study in pigs.

van Ijken MG, de Bruijn EA, de Boeck G, ten Hagen TL, van der Sijp JR, Eggermont AM. van Ijken MG, et al. Among authors: de bruijn ea, de boeck g. Ann Surg. 1998 Dec;228(6):763-70. doi: 10.1097/00000658-199812000-00007. Ann Surg. 1998. PMID: 9860475 Free PMC article.

7

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion.

de Wilt JH, ten Hagen TL, de Boeck G, van Tiel ST, de Bruijn EA, Eggermont AM. de Wilt JH, et al. Among authors: de bruijn ea, de boeck g. Br J Cancer. 2000 Mar;82(5):1000-3. doi: 10.1054/bjoc.1999.1032. Br J Cancer. 2000. PMID: 10737379 Free PMC article.

8

Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-alpha-based isolated hepatic perfusion.

van Etten B, de Vries MR, van IJken MG, Lans TE, Guetens G, Ambagtsheer G, van Tiel ST, de Boeck G, de Bruijn EA, Eggermont AM, ten Hagen TL. van Etten B, et al. Among authors: de vries mr, de bruijn ea, de boeck g. Br J Cancer. 2003 Jan 27;88(2):314-9. doi: 10.1038/sj.bjc.6600707. Br J Cancer. 2003. PMID: 12610519 Free PMC article.

9

Balloon catheter hypoxic abdominal and pelvic perfusion with tumour necrosis factor-alpha, Melphalan and Mitomycin C: a pharmacokinetic study in pigs.

van IJken MG, de Bruijn EA, ten Hagen TL, de Boeck G, van Eijck CH, Eggermont AM. van IJken MG, et al. Among authors: de bruijn ea, de boeck g. Eur J Surg Oncol. 2004 Aug;30(6):699-707. doi: 10.1016/j.ejso.2004.03.015. Eur J Surg Oncol. 2004. PMID: 15256247

10

Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study.

van Etten B, Brunstein F, van IJken MG, Marinelli AW, Verhoef C, van der Sijp JR, Guetens G, de Boeck G, de Bruijn EA, de Wilt JH, Eggermont AM. van Etten B, et al. Among authors: de bruijn ea, de boeck g, de wilt jh. Ann Surg Oncol. 2004 Jun;11(6):598-605. doi: 10.1245/ASO.2004.09.021. Ann Surg Oncol. 2004. PMID: 15172933 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters